Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.35 USD | -3.57% | -6.90% | -28.57% |
Jun. 05 | Sector Update: Health Care Stocks Rise Wednesday Afternoon | MT |
Jun. 05 | Adicet Bio Says US FDA Grants Fast Track Designation for ADI-001 to Treat Lupus Nephritis | MT |
Business Summary
Number of employees: 143
Managers
Managers | Title | Age | Since |
---|---|---|---|
Aya Jakobovits
FOU | Founder | 71 | 14-10-31 |
Chen Schor
CEO | Chief Executive Officer | 51 | 16-06-30 |
Brian Harvey
DFI | Director of Finance/CFO | 63 | 20-08-31 |
Blake Aftab
CTO | Chief Tech/Sci/R&D Officer | 43 | 21-04-12 |
Francesco Galimi
CTO | Chief Tech/Sci/R&D Officer | 56 | 19-08-31 |
Donald Healey
CTO | Chief Tech/Sci/R&D Officer | 62 | 20-10-25 |
Anne Bowdidge
IRC | Investor Relations Contact | - | - |
Amy Locke
HRO | Human Resources Officer | - | 22-01-31 |
Nancy L. Boman
LAW | General Counsel | - | 22-11-28 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Steve Dubin
BRD | Director/Board Member | 70 | 20-09-14 |
Carl Gordon
CHM | Chairman | 59 | 15-08-14 |
Michael Kauffman
BRD | Director/Board Member | 60 | 21-11-16 |
Chen Schor
CEO | Chief Executive Officer | 51 | 16-06-30 |
Aya Jakobovits
FOU | Founder | 71 | 14-10-31 |
Andrew Sinclair
BRD | Director/Board Member | 52 | 21-03-01 |
Director/Board Member | 68 | 20-09-14 | |
Katie Peng
BRD | Director/Board Member | 53 | 23-07-09 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 82,173,503 | 80,897,705 ( 98.45 %) | 0 | 98.45 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.57% | 111M | |
+51.85% | 57.87B | |
+41.11% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- ACET Stock
- Company Adicet Bio, Inc.